Xenon Pharmaceuticals Inc. (XENE) financial statements (2021 and earlier)

Company profile

Business Address 200 - 3650 GILMORE WAY
BURNABY, BC V5G 48W
State of Incorp. BC
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments17714111944645984
Cash and cash equivalents45256820175972
Short-term investments132117522347 12
Receivables2100000
Other undisclosed current assets3321121
Total current assets:18214512145666185
Noncurrent Assets
Operating lease, right-of-use asset31
Property, plant and equipment4211122
Prepaid expense   001 
Deferred income tax assets1 
Other undisclosed noncurrent assets 0     
Total noncurrent assets:7311232
TOTAL ASSETS:18914812246676487
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:11943433
Accounts payable3211111
Accrued liabilities0000000
Employee-related liabilities3321111
Other undisclosed accounts payable and accrued liabilities5311111
Deferred revenue430
Debt 5 1   
Deferred revenue and credits  012
Other undisclosed current liabilities0      
Total current liabilities:1543444314
Noncurrent Liabilities
Long-term debt and lease obligation312156   
Long-term debt, excluding current maturities 11156   
Operating lease, liability31
Liabilities, other than long-term debt 1  000
Deferred revenue and credits 000
Deferred revenue 1
Other undisclosed noncurrent liabilities(3)      
Total noncurrent liabilities:312156000
Total liabilities:185619104315
Stockholders' equity
Stockholders' equity attributable to parent1719210336646173
Preferred stock888    
Common stock398294266174173149147
Additional paid in capital45413936343330
Accumulated other comprehensive loss(1)(1)(1)(1)(1)(1)(1)
Accumulated deficit(278)(250)(208)(173)(143)(120)(104)
Total stockholders' equity:1719210336646173
TOTAL LIABILITIES AND EQUITY:18914812246676487

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenue, net021628
Net investment income421    
Gross profit:3271021628
Operating expenses(63)(50)(38)(33)(27)(25)(17)
Other undisclosed operating loss  (1)    
Operating income (loss):(31)(43)(38)(33)(25)(9)11
Nonoperating income (expense)43522(6)2
Investment income, nonoperating2210111
Gain on contract termination  4    
Foreign currency transaction gain (loss), before tax10(1)11(7)1
Interest and debt expense(1)(1)(1)    
Income (loss) from continuing operations before income taxes:(29)(42)(34)(31)(23)(16)13
Income tax benefit00     
Net income (loss) attributable to parent:(29)(42)(34)(31)(23)(16)13
Other undisclosed net income available to common stockholders, basic123    
Net income (loss) available to common stockholders, basic:(28)(40)(32)(31)(23)(16)13
Dilutive securities, effect on basic earnings per share   (0)   
Net income (loss) available to common stockholders, diluted:(28)(40)(32)(31)(23)(16)13

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(29)(42)(34)(31)(23)(16)13
Comprehensive income (loss):(29)(42)(34)(31)(23)(16)13
Other undisclosed comprehensive loss, net of tax, attributable to parent      (4)
Comprehensive income (loss), net of tax, attributable to parent:(29)(42)(34)(31)(23)(16)10

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: